Requests that the FDA declare that Semaglutide Injection, 1mg/1.5 mL (0.68 mg/mL), 2mg/1.5 mL (1.34 mg/mL), 4mg/3 mL (1.34 mg/mL), 6.8mg/3 mL (2.27 mg/mL), 9.6mg/3 mL (3.2 mg/mL) in pre-filled, disposable and multi-dose pen injector, is suitable for submission as an ANDA